Patents by Inventor Corey Patrick Mallett

Corey Patrick Mallett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INFLUENZA VIRUS VACCINATION REGIMENS
    Publication number: 20190125859
    Abstract: Provided herein are immunization regimens for inducing an immune response (e.g., and antibody response) against influenza virus. In specific aspects, the immunization regimens involve the administration of a chimeric hemagglutinin (HA), a headless HA or another influenza virus stem domain based construct (e.g., the HA stem domain or a fragment thereof) to a subject. In certain aspects, the immunization regimens also involve the administration of an influenza virus neuraminidase immunogen. Also provided herein are immunogenic/vaccine compositions for use in methods of immunizing or immunization regimens for human subjects against influenza virus.
    Type: Application
    Filed: June 1, 2017
    Publication date: May 2, 2019
    Applicants: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Peter PALESE, Adolfo GARCIA-SASTRE, Florian KRAMMER, Raffael NACHBAGAUER, Bruce INNIS, Corey Patrick MALLETT
  • Immunogenic composition
    Patent number: 9161975
    Abstract: The present invention relates to the use of a immunogenic or immunostimulatory composition comprising a Shigella outer membrane protein (OMP) and Shigella LPS molecule in medicine and methods for preparing the composition.
    Type: Grant
    Filed: October 27, 2011
    Date of Patent: October 20, 2015
    Assignee: GlaxoSmithKline Biologicals, S.A.
    Inventors: Normand Blais, Anne-Marie Lanteigne, Daniel Larocque, Corey Patrick Mallett
  • NOVEL VACCINE
    Publication number: 20140242112
    Abstract: The present invention provides an immunogenic composition comprising one or more antigens and a Toll-like receptor (TLR) 7 agonist in an orally (e.g. sublingually) administered composition.
    Type: Application
    Filed: April 25, 2014
    Publication date: August 28, 2014
    Applicant: GlaxoSmithKline Biologicals S.A.
    Inventors: Nadia Ouaked, Martin Plante, Daniel Larocque, Corey Patrick Mallett
  • IMMUNOGENIC COMPOSITION
    Publication number: 20130224266
    Abstract: The present invention relates to the use of a immunogenic or immunostimulatory composition comprising a Shigella outer membrane protein (OMP) and Shigella LPS molecule in medicine and methods for preparing the composition.
    Type: Application
    Filed: October 27, 2011
    Publication date: August 29, 2013
    Applicant: GlaxoSmithKline Biologicals S.A.
    Inventors: Normand Blais, Anne-Marie Lanteigne, Daniel Larocque, Corey Patrick Mallett
  • ORAL VACCINE COMPROMISING AN ANTIGEN AND A TOLL-LIKE RECEPTOR AGONIST
    Publication number: 20130089570
    Abstract: The present invention provides an immunogenic composition comprising one or more antigens and a Toll-like receptor (TLR) agonist in an orally (e.g. sublingually) administered composition.
    Type: Application
    Filed: February 6, 2011
    Publication date: April 11, 2013
    Applicant: Glaxo Smith Kline Biologicals S.A.
    Inventors: Nadia Ouaked, Martin Plante, Daniel Larocque, Corey Patrick Mallett